Fig. 8.
vLeu262Proβ3 on 293 cells retracts a fibrin clot.
Untransfected 293 cells (solid circles) and cells expressing WT αvβ3 (solid squares) or αvLeu262Proβ3 (open circles) were assessed for their ability to retract clotted fibronectin-depleted plasma (A) or purified fibrinogen (B). The estimated clot volume is expressed as a function of time (minutes). The data shown are representative results from 3 separate experiments. αvLeu262Proβ3-mediated clot retraction was comparable to that of WT αvβ3. (C) WT αvβ3 cells (open columns) or αvLeu262Proβ3 cells (solid columns) were incubated for 15 minutes at 22°C with peptides RGDW, RGEW, or H12 (all at a final concentration of 2 mmol/L) or with the indicated antibodies (final concentration, 10 μg/mL). Only RGDW and the αvβ3-specific antibody LM609 fully inhibited clot retraction.